MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 28 filers reported holding MEDGENICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,044,000 | +19.5% | 187,500 | +19.0% | 0.02% | +14.3% |
| Q2 2016 | $874,000 | +66.8% | 157,500 | +32.4% | 0.01% | +55.6% |
| Q1 2016 | $524,000 | -26.8% | 119,000 | 0.0% | 0.01% | -30.8% |
| Q4 2015 | $716,000 | -23.1% | 119,000 | 0.0% | 0.01% | -31.6% |
| Q3 2015 | $931,000 | +27.7% | 119,000 | 0.0% | 0.02% | +35.7% |
| Q2 2015 | $729,000 | +14.6% | 119,000 | +50.6% | 0.01% | +7.7% |
| Q1 2015 | $636,000 | +78.7% | 79,000 | +12.2% | 0.01% | +62.5% |
| Q4 2014 | $356,000 | -14.2% | 70,386 | -12.0% | 0.01% | -20.0% |
| Q3 2014 | $415,000 | -33.3% | 80,000 | 0.0% | 0.01% | -37.5% |
| Q2 2014 | $622,000 | +11.5% | 80,000 | 0.0% | 0.02% | 0.0% |
| Q1 2014 | $558,000 | +132.5% | 80,000 | +100.0% | 0.02% | +128.6% |
| Q4 2013 | $240,000 | -55.6% | 40,000 | -42.4% | 0.01% | -61.1% |
| Q3 2013 | $541,000 | +161.4% | 69,400 | +27.6% | 0.02% | +125.0% |
| Q2 2013 | $207,000 | – | 54,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,058,400 | $8,277,000 | 4.07% |
| Belmont Global Advisors, Inc. | 155,000 | $1,212,000 | 2.06% |
| Broadfin Capital, LLC | 1,545,306 | $12,084,000 | 0.67% |
| CARL DOMINO INC | 34,134 | $267,000 | 0.21% |
| QVT Financial LP | 267,608 | $2,093,000 | 0.07% |
| WHITE PINE CAPITAL LLC | 20,000 | $156,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119,000 | $931,000 | 0.02% |
| HYMAN CHARLES D | 13,000 | $102,000 | 0.02% |
| Kavar Capital Partners, LLC | 1,500 | $11,000 | 0.01% |
| Brick & Kyle, Associates | 1,000 | $8,000 | 0.01% |